Opdivo® (Nivolumab) Intravenous Infusion Approved for Supplemental Indication of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with Disease Progression on or after Platinum-based Therapy in Taiwan 2017.08.16
Category: JPN
Cerberus Sells Out Seibu Shareholdings 20170816
HondaJet Obtains Brazilian Type Certification. Aug 15, 2017 – GREENSBORO, N.C.
MAZDA ( 17V457000 ) – US Recall News. NHTSA Campaign Number: 17V457000